Assessing the safety of new germicidal far‐UVC technologies
Photochemistry and Photobiology · 2024-05 · 100 (3) · 501-520
DOI: 10.1111/php.13866 ↗At a glance
Übersichtsarbeit in Photochemistry and Photobiology, published online on 2023-11-06. Written by Maximilian Görlitz and 29 co-authors. Institution: Massachusetts Institute of Technology, Media Lab, Cambridge, Massachusetts, USA. Major MEDLINE topics: Ultraviolet Rays, Disinfection, COVID-19. Cited 68 times so far (Crossref); 159 references.
Abstract (original language)
The COVID‐19 pandemic underscored the crucial importance of enhanced indoor air quality control measures to mitigate the spread of respiratory pathogens. Far‐UVC is a type of germicidal ultraviolet technology, with wavelengths between 200 and 235 nm, that has emerged as a highly promising approach for indoor air disinfection. Due to its enhanced safety compared to conventional 254 nm upper‐room germicidal systems, far‐UVC allows for whole‐room direct exposure of occupied spaces, potentially offering greater efficacy, since the total room air is constantly treated. While current evidence supports using far‐UVC systems within existing guidelines, understanding the upper safety limit is critical to maximizing its effectiveness, particularly for the acute phase of a pandemic or epidemic when greater protection may be needed. This review article summarizes the substantial present knowledge on far‐UVC safety regarding skin and eye exposure and highlights research priorities to discern the maximum exposure levels that avoid adverse effects. We advocate for comprehensive safety studies that explore potential mechanisms of harm, generate action spectra for crucial biological effects and conduct high‐dose, long‐term exposure trials. Such rigorous scientific investigation will be key to determining safe and effective levels for far‐UVC deployment in indoor environments, contributing significantly to future pandemic preparedness and response.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Massachusetts Institute of Technology, Media Lab, Cambridge, Massachusetts, USA.
- SecureBio, Inc., Cambridge, Massachusetts, USA.
- Centre de recherche du CHU de Québec-Université Laval, Axe Médecine Régénératrice Quebec, Quebec City, Quebec, Canada.
- Center for Radiological Research, Columbia University Medical Center, New York City, New York, USA.
- Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York City, New York, USA.
- Photobiology Unit, Ninewells Hospital, Dundee, UK.
ORCID profiles: Maximilian Görlitz, Manuela Buonanno, Ewan Eadie, Sachiko Kaidzu, Paul Jensen, Chikako Nishigori, Paul Donald Forbes, David Sliney
Cite
APA
Görlitz, M., Justen, L., Rochette, P. J., Buonanno, M., Welch, D., Kleiman, N. J., Eadie, E., Kaidzu, S., Bradshaw, W. J., Javorsky, E., Cridland, N., Galor, A., Guttmann, M., Meinke, M. C., Schleusener, J., Jensen, P., Söderberg, P., Yamano, N., Nishigori, C., …, & Esvelt, K. (2024). Assessing the safety of new germicidal far‐UVC technologies. Photochemistry and Photobiology, 100(3), 501-520. https://doi.org/10.1111/php.13866
Vancouver
Görlitz M, Justen L, Rochette PJ, Buonanno M, Welch D, Kleiman NJ, et al. Assessing the safety of new germicidal far‐UVC technologies. Photochemistry and Photobiology. 2024;100(3):501-520. doi:10.1111/php.13866
BibTeX
@article{Grlitz2024,
author = {Görlitz, Maximilian and Justen, Lennart and Rochette, Patrick J and Buonanno, Manuela and Welch, David and Kleiman, Norman J and Eadie, Ewan and Kaidzu, Sachiko and Bradshaw, William J and Javorsky, Emilia and Cridland, Nigel and Galor, Anat and Guttmann, Martin and Meinke, Martina C and Schleusener, Johannes and Jensen, Paul and Söderberg, Per and Yamano, Nozomi and Nishigori, Chikako and O'Mahoney, Paul and Manstein, Dieter and Croft, Rodney and Cole, Curtis and de Gruijl, Frank R and Forbes, Paul Donald and Trokel, Stephen and Marshall, John and Brenner, David J and Sliney, David and Esvelt, Kevin},
title = {Assessing the safety of new germicidal far‐UVC technologies},
journal = {Photochemistry and Photobiology},
year = {2024},
volume = {100},
number = {3},
pages = {501--520},
doi = {10.1111/php.13866}
}
EUVIMED